Regulations.gov document
Email Correspondence from FDA CDER to Newcastle Bioscience LLC
Other · FDA-2023-P-4321 · posted Feb 2, 2024
Key facts
| Document ID | FDA-2023-P-4321-0011 |
|---|---|
| Title | Email Correspondence from FDA CDER to Newcastle Bioscience LLC |
| Document type | Other |
| Subtype | Correspondence |
| Agency | FDA |
| Docket | FDA-2023-P-4321 |
| Posted | Feb 2, 2024 |
| Comment period opens | Feb 2, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: